Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Imperial Ginseng Products Ltd IGPFF


Primary Symbol: V.IGP

Consumer Defensive Farm Products
Imperial Ginseng Products Ltd. is a Canada-based company. The Company’s principal business was cultivating and processing North American ginseng in Ontario and selling the dried ginseng, almost exclusively to wholesalers in China, through a distributor. The Company has ceased its ginseng operation and is in the process of considering alternative business propositions and opportunities in... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:IGP)

Canadian Investment Regulatory Organization Trade Resumption - IGP

Canada NewsWire December 22, 2023

Imperial Ginseng Products Ltd. Announces Cash Distribution

GlobeNewswire December 22, 2023

Canadian Investment Regulatory Organization Trading Halt - IGP

Canada NewsWire December 22, 2023

Imperial Ginseng Products Ltd. Announces Cancellation of Stock Options Granted in 2017

GlobeNewswire January 20, 2021

Imperial Ginseng Products Ltd. Announces Grant of Stock Options

GlobeNewswire January 13, 2021

Imperial Ginseng Products Ltd. Announces Changes in Future Operating Plan

GlobeNewswire October 22, 2020

Imperial Ginseng (TSXV:IGP) aborts crop plans as market struggles

Elise Kelly October 22, 2020

Imperial Ginseng Products Ltd. Announces New Planting Decision and Retirement of Director

GlobeNewswire May 28, 2020

Imperial Ginseng Products Ltd. Announces Renewal of Normal Course Issuer Bid

GlobeNewswire September 5, 2019
View More News ››

Opinion & Analysis (TSXV:IGP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:IGP)

impressive rally yesterday

up   66%   in one day.  
pennydredful - March 13, 2024

Anybody

recieve   the   2.25    payment    today   ?
pennydredful - January 26, 2024

RE:“Due Bill”

Anybody   know  whats   left   after   the    2.25   distribution  ...
pennydredful - January 2, 2024

RE:RE:RE:Payday approaching

So much for zero. $2.25 cash for the patient.
undervalue - December 22, 2023

“Due Bill”

The Distribution described in this news release is the one and only distribution from liquidating the Company’s ginseng business...
Betteryear2 - December 22, 2023

Imperial Ginseng Products Ltd. Announces Cash Distribution

VANCOUVER, British Columbia, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Imperial Ginseng Products Ltd. (TSXV: IGP) (the “Company”) today announces...
Betteryear2 - December 22, 2023
View more Bullboard ››

NurExone Biologic Inc

NurExone Biologic Inc

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ...
View More »